Surgical and oncological outcomes after laparoscopic vs. open major hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.

Abstract

BackgroundThe short- and long-term prognoses are unclear following laparoscopic major hepatectomy (LMH) for hepatocellular carcinoma (HCC). We performed a meta-analysis to compare the surgical and oncological outcomes of LMH vs. open major hepatectomy (OMH) in patients with HCC.MethodsAll studies comparing LMH with OMH for HCC published until April 2019 were identified independently by searching PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials. We analyzed data for surgical and oncological outcomes, namely, operative time, intraoperative blood loss, blood transfusion rate, postoperative morbidity, major complications, mortality, hospital stay, margin distance, negative margin rate, long-term overall survival, and corresponding disease-free survival (DFS).ResultsWe included 13 studies involving 1,225 patients with HCC (LMH: 534 patients; OMH: 691 patients) in the meta-analysis. Regarding short-term outcomes, the pooled data showed that LMH was associated with longer operative time [weighted mean difference (WMD): 72.14 min; 95% confidence interval (CI): 43.07–101.21; P<0.00001], less blood loss (WMD: −102.32 mL; 95% CI: −150.99 to −53.64; P<0.0001), shorter hospital stay (WMD: −3.77 d; 95% CI: −4.95 to −2.60; P<0.00001), lower morbidity [risk difference (RD): −0.01; 95% CI: −0.16 to −0.06; P<0.00001], and lower major complication rates (RD: −0.08; 95% CI: −0.11 to −0.05; P<0.00001). However, the need for blood transfusion (RD: −0.01; 95% CI: −0.06 to 0.05; P=0.78), mortality (RD: −0.01; 95% CI: −0.02 to 0.01; P=0.57), margin distance (WMD: 0.05 mm; 95% CI: −0.1 to 0.19; P=0.52), and negative margin rate (RD: 0.01; 95% CI: −0.03 to 0.05; P=0.65) were significantly comparable between the two groups. Regarding long-term outcomes, there was no difference in 3-year DFS [hazard ratio (HR): 0.99; 95% CI: 0.72–1.37; P=0.95], 3-year overall survival (HR: 1.25; 95% CI: 0.70–2.21; P=0.45), 5-year DFS (HR: 0.94; 95% CI: 0.64–1.38; P=0.76), and 5-year overall survival (HR: 0.94; 95% CI: 0.45–1.99; P=0.88).ConclusionsLMH can be performed as safely as OMH in select patients and provides improved short-term surgical outcomes without affecting long-term survival. However, confirming our results requires more evidence from high-quality and prospective randomized controlled trials.